Adélaïde De Mauléon

Neuropsychiatric Symptoms and Risk of Progression to Alzheimer’s Disease Among Mild Cognitive Impairment Subjects

Simon Dietlin, María Soto, Vera Kiyasova et al. · Journal of Alzheimer s Disease · 2019 · 95 citations

Medicine, Neurology, Psychiatry +17

Costs of Care of Agitation Associated With Dementia in 8 European Countries: Results From the RightTimePlaceCare Study

Nadège Costa, Ansgar Wübker, Adélaïde De Mauléon et al. · Journal of the American Medical Directors Association · 2017 · 65 citations · Full text

Medicine, Geriatric Medicine, Pharmacoeconomics +12

Guidance for the Prevention of the COVID-19 Epidemic in Long-Term Care Facilities: A Short-Term Prospective Study

Yves Rolland, M.-H. Lacoste, Adélaïde De Mauléon et al. · The journal of nutrition health & aging · 2020 · 41 citations · Full text

Medicine, Infectious Diseases, Preventive Medicine +13

Associated Factors With Antipsychotic Use in Long-Term Institutional Care in Eight European Countries: Results From the RightTimePlaceCare Study

Adélaïde De Mauléon, Sandrine Sourdet, Anna Renom‐Guiteras et al. · Journal of the American Medical Directors Association · 2014 · 35 citations · Full text

Medicine, Health Sciences, Psychiatry +16

Agitation in Alzheimer's disease: Novel outcome measures reflecting the International Psychogeriatric Association (IPA) agitation criteria

Adélaïde De Mauléon, Zahinoor Ismail, Paul B. Rosenberg et al. · Alzheimer s & Dementia · 2021 · 34 citations · Full text

Medicine, Neurology, Psychiatry +12